Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · IEX Real-Time Price · USD
2.800
-0.130 (-4.44%)
At close: Jul 19, 2024, 12:00 AM
2.790
-0.010 (-0.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Evaxion Biotech Employees
Evaxion Biotech had 49 employees as of December 31, 2023. The number of employees decreased by 14 or -22.22% compared to the previous year.
Employees
49
Change (1Y)
-14
Growth (1Y)
-22.22%
Revenue / Employee
$1,490
Profits / Employee
-$451,531
Market Cap
14.60M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49 | -14 | -22.22% |
Dec 31, 2022 | 63 | 2 | 3.28% |
Dec 31, 2021 | 61 | 26 | 74.29% |
Dec 31, 2020 | 35 | -1 | -2.78% |
Dec 31, 2019 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Centogene | 384 |
Star Equity Holdings | 171 |
Flora Growth | 108 |
BriaCell Therapeutics | 16 |
Talphera | 15 |
Galecto | 13 |
XTL Biopharmaceuticals | 7 |
Immuron | 6 |
EVAX News
- 6 days ago - Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference - GlobeNewsWire
- 19 days ago - Evaxion Reinforces Milestone Timeline and Provides Shareholder Update - GlobeNewsWire
- 26 days ago - Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method - GlobeNewsWire
- 5 weeks ago - Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal - GlobeNewsWire
- 7 weeks ago - Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024 - GlobeNewsWire
- 7 weeks ago - Evaxion Announces Business Update and First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024 - GlobeNewsWire
- 2 months ago - Evaxion Receives Nasdaq Notification - GlobeNewsWire